Our Recommendations
- Mpox Continental Preparedness and Response Plan for Africa (2024)
- Tests diagnostiques pour la détection du virus de la variole simienne (orthopoxvirus simien, ou MPXV) (2024)
- Monkeypox: Caring for the skin (2022)
- Landscape of Therapeutics licensed or under development for Mpox (2024)
- Landscape of vaccines licensed or under development for Mpox (2024)
New Publications
- Strategic Framework for Enhancing Prevention and Control of mpox, 2024-2027 (2024)
- Considerations for border health and points of entry for mpox: interim guidance (2024)
- Mpox Continental Preparedness and Response Plan for Africa (2024)
- Flyer Mpox (2024)
- Guidance for WASH practitioners on Mpox (August 2024) (2024)
Filter
37
Featured
Recommendations
6
Language
Document type
Fact sheets
7
Guidelines
6
Infographics
5
No document type
5
Training Material
4
Resource Platforms
3
Strategic & Response Plan
3
Studies & Reports
2
Videos
2
Countries / Regions
Global
1
Authors & Publishers
Publication Years
Category
MPOX - Monkeypox
13
x MEDBOX Issue Brief & Annual Reports x
2
Infection Control & Prevention (IPC)
1
Toolboxes
MPOX -Monkeybox Prevention & Control
37
MPOX - Monkeypox
19
MPOX - Monkeypox
9
IPC
1
Zoonoses
1
Surveillance, case investigation and contact tracing for monkeypox: interim guidance 24 June 2022
recommended
The overall goal of surveillance, case investigation and contact tracing in this context is to stop human-to-human transmission to control the outbreak. The key objectives of surveillance and case investigation are to rapidly identify cases and clusters in order to provide optimal clinical care; to ...
Cases of monkeypox (MPX) acquired in the EU have recently been reported in nine EU Member States (Austria, Belgium, France, Germany, Italy, Portugal, Spain, Sweden, and the Netherlands).
Monkeypox (MPX) does not spread easily between people. Human-to-human transmission occurs through close contact ...
The purpose of this document is to provide public health advice to host governments, public health authorities, national or international organizers, and professional staff involved in the planning and delivery of gatherings, including people organizing smaller gatherings or attending gatherings of ...
ummer is here and there are a lot of great opportunities for people to gather and enjoy themselves. Public health authorities are working together with event organisers and civil society organisations to reach out to people attending events, including at-risk groups, about monkeypox in Europe. This ...
Key Priorities 27 June 2022
MEDBOX Issue Brief no.22, updated August 9, 2022
Protecting yourself in festivals and parties. Wath the video recording
WHO invites Member States, health facilities and other entities to participate in the global effort to collect anonymized clinical data relating to suspected or confirmed cases of monkeypox and contribute data to the WHO Global Clinical Platform.
WHO has developed a clinical characterization case ...
Which communities are most at risk of Monkeypox in the current outbreak and why? WHO’s Andy Seale explains how we can support the communities at risk in Science in 5.
Monkeypox is a rare viral zoonotic disease caused by a double stranded DNA virus that belongs to the Orthopoxvirus genus of the Poxviridae family.
The advice on this page provides information for individuals and families on ways to prevent illness and stay healthy, based on WHO recommendations.
This Mpox SPRP Global Monitoring & Evaluation (M&E) Framework, also referred to as the Framework, aims to monitor and report on global progress towards these objectives, including information about country-level response efforts and WHO support to Member States. Regular collection and analysis of da...
The monkeypox virus (MPXV) clade I epidemic that has been affecting the Democratic Republic of the Congo
(DRC) since November 2023 has recently spread to several other African countries including Burundi, Rwanda,
Uganda and Kenya. The size of these outbreaks could be larger than reported due to un...
The tab is the result of a preliminary landscape of vaccines licensed or under development for Mpox
The tab is the result of a preliminary landscape of therapeutics licensed or under development for Mpox
L’orthopoxvirus simien ou virus de la variole du singe (MPXV), est un virus à ADN double brin qui appartient au genre Orthopoxvirus de la famille
des Poxviridés. Les poxvirus causent des maladies chez l’espèce humaine et beaucoup d’autres animaux ; l’infection se manifeste généralement...
